Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
MXL Stock Summary
Top 10 Correlated ETFs
MXL
In the News

Not Worth It! 3 Risky Stocks to Get Rid Of Now
The October CPI report showed a lower-than-expected inflation rate, boosting the market sentiment and sparking a rally across various sectors. However, not all stocks are poised to benefit from positive macroeconomic news.

1 Small Chip Stock to Consider for a New Era of AI
SiliconMotion has seemingly begun its rebound from lows reached earlier this year. The company is a way to play a rebound in PC and smartphone sales, with a bump perhaps coming from on-device AI.

Why MaxLinear Stock Is Plummeting Today
MaxLinear's Q3 sales and earnings results fell short of Wall Street's targets. The company's forward guidance was also concerning.

MaxLinear, Inc. (MXL) Q3 2023 Earnings Call Transcript
MaxLinear, Inc. (NASDAQ:MXL ) Q3 2023 Earnings Conference Call October 25, 2023 4:30 PM ET Company Participants Leslie Green - Investor Relations Kishore Seendripu - Chief Executive Officer Steven Litchfield - Chief Financial Officer and Chief Corporate Strategy Officer Conference Call Participants Tore Svanberg - Stifel Financial Corp. Quinn Bolton - Needham & Company Gary Mobley - Wells Fargo Securities LLC Christopher Rolland - Susquehanna International Group, LLP Ross Seymore - Deutsche Bank David Williams - The Benchmark Company, LLC Karl Ackerman - BNP Paribas Ananda Baruah - Loop Capital Markets Suji Desilva - ROTH MKM Operator Greetings. Welcome to MaxLinear Third Quarter 2023 Earnings Conference Call.

MaxLinear (MXL) Lags Q3 Earnings and Revenue Estimates
MaxLinear (MXL) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $1.05 per share a year ago.

MaxLinear, Inc. Announces Conference Call to Review Third Quarter 2023 Financial Results Wednesday, October 25, 2023 at 1:30 p.m. Pacific Time; 4:30 p.m.
CARLSBAD, Calif.--(BUSINESS WIRE)--MaxLinear announces Q3 2023 earnings conference call to occur on Wednesday, October 25, 2023 at 1:30pm PDT / 4:30pm EDT.

3 Semiconductor Stocks to Sell While You Still Can
Semiconductor-producing companies are vital to the global economy because most electronic equipment, such as smartphones, vehicles, televisions, refrigerators and medical care devices require the technology. The VanEck Semiconductor ETF (NASDAQ: SMH ) is a popular metric for tracking the industry as a whole.

MaxLinear: Uncertainty To Remain The Name Of The Game
MaxLinear experienced volatility in its share price after outlining a dismal third quarter outlook and terminating a deal with Silicon Motion Technology Corporation. The company's sales and profits fluctuated, with strong growth and M&A activity in 2020 and through 2022, but a big decline so far this year. The termination of the deal with Silicon Motion has resulted in a legal overhang and uncertainty for investors, making it unattractive to invest in MaxLinear at this time.

3 Chip Stocks That Should Be on Every Investor's Radar
The semiconductor sector has been on a tear in 2023, but while giants like Nvidia (NASDAQ: NVDA ) get all the headlines, some hidden gems are still waiting to be discovered. Sure, the bigger players can still climb higher, but the risk-reward ratio tends to favor the small caps in times like these.

The 7 Best Sleeper Stocks to Buy in August
While it's tempting on many levels to ride the flavors of the week, investors seeking long-term growth should consider the best sleeper stocks to buy. These securities feature very little investor interest for whatever reason.
MXL Financial details
MXL Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.62 | 4.47 | 6.54 | 11.74 | 14.36 | |
Net income per share | -0.38 | -0.28 | -1.35 | 0.55 | 1.6 | |
Operating cash flow per share | 1.5 | 1.1 | 1.01 | 2.21 | 4.98 | |
Free cash flow per share | 1.39 | 1.01 | 0.8 | 1.6 | 4.31 | |
Cash per share | 1.07 | 1.31 | 2.04 | 1.72 | 2.64 | |
Book value per share | 5.84 | 5.84 | 5.35 | 6.43 | 8.67 | |
Tangible book value per share | -1.22 | -0.16 | -1.63 | 0.39 | 3.34 | |
Share holders equity per share | 5.84 | 5.84 | 5.35 | 6.43 | 8.67 | |
Interest debt per share | 3.96 | 3.27 | 5.55 | 4.64 | 2.12 | |
Market cap | 1.21B | 1.51B | 2.79B | 5.73B | 2.65B | |
Enterprise value | 1.39B | 1.63B | 3.03B | 5.93B | 2.62B | |
P/E ratio | -46.01 | -75.72 | -28.33 | 136.59 | 21.19 | |
Price to sales ratio | 3.13 | 4.75 | 5.84 | 6.42 | 2.37 | |
POCF ratio | 11.74 | 19.23 | 37.95 | 34.07 | 6.82 | |
PFCF ratio | 12.71 | 21.11 | 47.9 | 47.19 | 7.88 | |
P/B Ratio | 3.01 | 3.63 | 7.14 | 11.72 | 3.92 | |
PTB ratio | 3.01 | 3.63 | 7.14 | 11.72 | 3.92 | |
EV to sales | 3.61 | 5.14 | 6.33 | 6.65 | 2.34 | |
Enterprise value over EBITDA | 20.88 | 34.19 | -141.07 | 37.06 | 9.7 | |
EV to operating cash flow | 13.52 | 20.81 | 41.15 | 35.26 | 6.73 | |
EV to free cash flow | 14.63 | 22.84 | 51.94 | 48.84 | 7.78 | |
Earnings yield | -0.02 | -0.01 | -0.04 | 0.01 | 0.05 | |
Free cash flow yield | 0.08 | 0.05 | 0.02 | 0.02 | 0.13 | |
Debt to equity | 0.64 | 0.53 | 1 | 0.69 | 0.23 | |
Debt to assets | 0.35 | 0.31 | 0.38 | 0.32 | 0.13 | |
Net debt to EBITDA | 2.75 | 2.59 | -10.97 | 1.25 | -0.12 | |
Current ratio | 2.56 | 2.73 | 1.55 | 1.95 | 1.65 | |
Interest coverage | -1.34 | -1.68 | -7.51 | 5.02 | 18.45 | |
Income quality | -3.92 | -3.94 | -0.75 | 4.01 | 3.11 | |
Dividend Yield | 0 | 0 | 0 | 0.06 | 0 | |
Payout ratio | 0 | 0 | 0 | 8.34 | 0 | |
Sales general and administrative to revenue | 0.26 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.31 | 0.31 | 0.38 | 0.31 | 0.26 | |
Intangibles to total assets | 0.65 | 0.6 | 0.5 | 0.44 | 0.35 | |
Capex to operating cash flow | -0.08 | -0.09 | -0.21 | -0.28 | -0.13 | |
Capex to revenue | -0.02 | -0.02 | -0.03 | -0.05 | -0.05 | |
Capex to depreciation | -0.1 | -0.11 | -0.2 | -0.51 | -0.65 | |
Stock based compensation to revenue | 0.08 | 0.1 | 0.1 | 0.07 | 0.07 | |
Graham number | 7.09 | 6.07 | 12.74 | 8.94 | 17.68 | |
ROIC | -0.02 | -0.02 | -0.1 | 0.07 | 0.15 | |
Return on tangible assets | -0.1 | -0.07 | -0.19 | 0.07 | 0.16 | |
Graham Net | -2.92 | -2.04 | -5.24 | -3.62 | -1.14 | |
Working capital | 110.04M | 115.21M | 128.06M | 196.71M | 222.04M | |
Tangible asset value | -83.29M | -11.38M | -118.98M | 29.99M | 260.33M | |
Net current asset value | -158.28M | -109.1M | -269.61M | -157.08M | 59.48M | |
Invested capital | 0.64 | 0.53 | 1 | 0.69 | 0.23 | |
Average receivables | 62.8M | 54.95M | 58.93M | 93.58M | 145.35M | |
Average payables | 16.26M | 14.52M | 23.1M | 42.86M | 60.78M | |
Average inventory | 47.59M | 36.62M | 64.67M | 114.77M | 146.12M | |
Days sales outstanding | 56.4 | 58.01 | 51.43 | 48.97 | 55.71 | |
Days payables outstanding | 32.29 | 32.82 | 44.97 | 48.76 | 53.2 | |
Days of inventory on hand | 86.45 | 76.93 | 134.35 | 121.22 | 124.55 | |
Receivables turnover | 6.47 | 6.29 | 7.1 | 7.45 | 6.55 | |
Payables turnover | 11.31 | 11.12 | 8.12 | 7.49 | 6.86 | |
Inventory turnover | 4.22 | 4.74 | 2.72 | 3.01 | 2.93 | |
ROE | -0.07 | -0.05 | -0.25 | 0.09 | 0.18 | |
Capex per share | -0.11 | -0.1 | -0.21 | -0.61 | -0.67 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.64 | 3.69 | 3.13 | 2.29 | 1.67 | |
Net income per share | 0.36 | 0.4 | 0.12 | -0.05 | -0.49 | |
Operating cash flow per share | 0.79 | 0.88 | 0.53 | 0.38 | -0.16 | |
Free cash flow per share | 0.6 | 0.66 | 0.46 | 0.26 | -0.19 | |
Cash per share | 2.55 | 2.62 | 2.85 | 3.05 | 2.48 | |
Book value per share | 7.85 | 8.6 | 9.24 | 9.27 | 8.65 | |
Tangible book value per share | 2.38 | 3.31 | 4.01 | 4.18 | 3.71 | |
Share holders equity per share | 7.85 | 8.6 | 9.24 | 9.27 | 8.65 | |
Interest debt per share | 2.67 | 2.01 | 1.96 | 2.04 | 1.99 | |
Market cap | 2.56B | 2.67B | 2.8B | 2.54B | 1.81B | |
Enterprise value | 2.58B | 2.64B | 2.73B | 2.47B | 1.77B | |
P/E ratio | 22.52 | 21.48 | 73.38 | -145.88 | -11.35 | |
Price to sales ratio | 8.95 | 9.19 | 11.26 | 13.8 | 13.34 | |
POCF ratio | 41.42 | 38.5 | 66.37 | 83.03 | -141.32 | |
PFCF ratio | 53.97 | 51.36 | 77.06 | 122.97 | -117.44 | |
P/B Ratio | 4.15 | 3.95 | 3.81 | 3.4 | 2.57 | |
PTB ratio | 4.15 | 3.95 | 3.81 | 3.4 | 2.57 | |
EV to sales | 9.04 | 9.08 | 11 | 13.41 | 13.07 | |
Enterprise value over EBITDA | 38.92 | 40.09 | 50.74 | 117.63 | -81.48 | |
EV to operating cash flow | 41.84 | 38.04 | 64.84 | 80.68 | -138.45 | |
EV to free cash flow | 54.51 | 50.75 | 75.28 | 119.49 | -115.05 | |
Earnings yield | 0.01 | 0.01 | 0 | 0 | -0.02 | |
Free cash flow yield | 0.02 | 0.02 | 0.01 | 0.01 | -0.01 | |
Debt to equity | 0.34 | 0.23 | 0.21 | 0.22 | 0.23 | |
Debt to assets | 0.18 | 0.13 | 0.13 | 0.14 | 0.14 | |
Net debt to EBITDA | 0.39 | -0.48 | -1.2 | -3.42 | 1.69 | |
Current ratio | 1.6 | 1.65 | 1.98 | 2.29 | 2.18 | |
Interest coverage | 19.16 | 17.96 | 10.97 | -2.29 | -6.56 | |
Income quality | 2.17 | 2.23 | 4.42 | -7.03 | 0.32 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.27 | 0.25 | 0.27 | 0.38 | 0.49 | |
Intangibles to total assets | 0.36 | 0.35 | 0.35 | 0.35 | 0.36 | |
Capex to operating cash flow | -0.23 | -0.25 | -0.14 | -0.32 | 0.2 | |
Capex to revenue | -0.05 | -0.06 | -0.02 | -0.05 | -0.02 | |
Capex to depreciation | -0.78 | -0.92 | -0.3 | -0.53 | -0.15 | |
Stock based compensation to revenue | 0.07 | 0.08 | 0.07 | 0.09 | 0.04 | |
Graham number | 8 | 8.74 | 4.99 | 3.36 | 9.77 | |
ROIC | 0.04 | 0.04 | 0.01 | -0.01 | -0.02 | |
Return on tangible assets | 0.04 | 0.04 | 0.01 | -0.01 | -0.06 | |
Graham Net | -1.91 | -1.13 | -0.27 | 0.12 | -0.29 | |
Working capital | 211.66M | 222.04M | 293.42M | 312.76M | 275.7M | |
Tangible asset value | 187M | 260.33M | 318.85M | 336.39M | 301.58M | |
Net current asset value | -3.84M | 59.48M | 129.22M | 139.06M | 107.5M | |
Invested capital | 0.34 | 0.23 | 0.21 | 0.22 | 0.23 | |
Average receivables | 157.57M | 174.52M | 179.85M | 172.28M | 157.03M | |
Average payables | 81.99M | 79.71M | 61.58M | 50.24M | 45.55M | |
Average inventory | 156.2M | 163.26M | 155.06M | 137.87M | 120.55M | |
Days sales outstanding | 56.09 | 52.95 | 68.37 | 76.25 | 105.08 | |
Days payables outstanding | 69.15 | 48.5 | 45.42 | 50.96 | 66.06 | |
Days of inventory on hand | 126.33 | 113.55 | 124.5 | 140.06 | 167.97 | |
Receivables turnover | 1.6 | 1.7 | 1.32 | 1.18 | 0.86 | |
Payables turnover | 1.3 | 1.86 | 1.98 | 1.77 | 1.36 | |
Inventory turnover | 0.71 | 0.79 | 0.72 | 0.64 | 0.54 | |
ROE | 0.05 | 0.05 | 0.01 | -0.01 | -0.06 | |
Capex per share | -0.18 | -0.22 | -0.07 | -0.12 | -0.03 |
MXL Frequently Asked Questions
What is MaxLinear, Inc. stock symbol ?
MaxLinear, Inc. is a US stock , located in Carlsbad of Ca and trading under the symbol MXL
Is MaxLinear, Inc. buy or a sell ?
9 stock analysts have 9 predictions with a medium analyst target price of $55. The lowest prediction is $45 and the highest is $66
What is MXL stock prediction ?
What is MaxLinear, Inc. stock quote today ?
MaxLinear, Inc. stock price is $19.39 today.
Is MaxLinear, Inc. stock public?
Yes, MaxLinear, Inc. is a publicly traded company.